PSTV - Plus Therapeutics stock jumps on $500000 share repurchase program
2023-10-31 16:17:53 ET
More on Plus Therapeutics
- Plus Therapeutics, Inc. (PSTV) Q2 2023 Earnings Call Transcript
- Biocept gains on licensing pact with Plus Therapeutics for cancer test
- Seeking Alpha’s Quant Rating on Plus Therapeutics
- Historical earnings data for Plus Therapeutics
- Financial information for Plus Therapeutics
For further details see:
Plus Therapeutics stock jumps on $500,000 share repurchase program